Founded in 1945 in Fort Worth, Texas, Alcon Inc. is a global medical company dedicated to eye care. The company's core mission is to provide innovative products that enhance sight and improve lives. Alcon offers a wide range of products, including surgical equipment for vitreoretinal and cataract procedures, contact lenses, and refractive technology solutions. Serving the global medical industry, Alcon focuses on advancing ophthalmology through cutting-edge technology and comprehensive eye care solutions.
Notable figures affiliated with Alcon include CEO David Endicott. The company is publicly traded on both the SIX Swiss Exchange and the New York Stock Exchange under the ticker symbol ALC. Alcon has achieved significant milestones, including generating a revenue of $9.46 billion in 2023. Its impact on the ophthalmology industry is profound, providing essential products that improve vision and quality of life for millions worldwide.